Vapogenix Inc. is a clinical-stage pharmaceutical company based in Houston, Texas, focused on developing non-opioid topical analgesics to alleviate pain at its source. Founded in 2006, the company has a small team of three and has secured significant funding to advance its lead product, VPX638, which aims to reduce opioid use while providing effective localized pain relief.